Xvivo Perfusion AB (publ)

XVIPY · OTC
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Operating Activities
Net Income$2-$12$36$88
Dep. & Amort.$17$16$38$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$7$0
Change in WC-$34-$32$11-$16
Other Non-Cash$25$13-$30-$49
Operating Cash Flow$9-$15$62$23
Investing Activities
PP&E Inv.-$36-$18-$22$0
Net Acquisitions$0$0-$50$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$36-$41-$39-$41
Investing Cash Flow-$72-$59-$111-$41
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$82-$3-$2-$3
Financing Cash Flow$82-$3-$2-$3
Forex Effect-$11-$22$17-$10
Net Chg. in Cash$7-$100-$34-$31
Supplemental Information
Beg. Cash$316$416$450$481
End Cash$323$316$416$450
Free Cash Flow-$27-$33$40$23